By Sean Murphy

Oklahoma voters will decide Tuesday whether to make the state one of the most conservative to green light cannabis use for adults.

State Question 820, the result of a signature gathering drive last year, is the only item on the statewide ballot. Other conservative states have legalized recreational cannabis use, including Montana in 2020 and Missouri last year, but several have rejected it, including Arkansas, North Dakota and South Dakota.

The plan faces opposition from leaders of several faith groups, along with law enforcement and prosecutors, led by former Republican Gov. Frank Keating, an ex-FBI agent, and Terri White, the former head of the state's Department of Mental Health and Substance Abuse Services.

“We don't want a stoned society,” Keating said Monday, flanked by district attorneys and law enforcement officers from across the state.

The proposal, if passed, would allow anyone over the age of 21 to purchase and possess up to 1 ounce of marijuana, plus concentrates and marijuana-infused products. People could also legally grow up to 12 marijuana plants. Recreational sales would be subjected to a 15% excise tax on top of the standard sales tax. The excise tax would be used to help fund local municipalities, the court system, public schools, substance abuse treatment and the state’s general revenue fund.

The proposal also outlines a judicial process for people to seek expungement or dismissal of prior marijuana-related convictions.

Oklahoma voters already approved medical marijuana in 2018 by 14 percentage points and the state has one of the most liberal programs in the country, with roughly 10% of the state’s adult population having a medical license.

The low barriers for entry into the industry has led to a flood of growers, processors and dispensary operators competing for a limited number of customers. Supporters also say the state's marijuana industry would be buoyed by a rush of out-of-state customers, particularly from Texas, which has close to 8 million people in the Dallas-Fort Worth area just a little more than an hour drive from the Oklahoma border.

“We do have one of the most permissible (medical) programs in the country, but the idea that you have to spend your time and money to go to a doctor and basically buy immunity from criminal prosecution is a pay-to-play system that I just don’t like,” said Ryan Kiesel, a former state lawmaker and one of the organizers of the Yes on 820 campaign.

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More